LivingGLP1
Study S002493

Screening and Intervention of Arteriosclerotic Cardiovascular Disease in Type 2 Diabetes in Zhejiang Province

Registration

Registration
NCT04866667
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
316
Start
2021-05-01
Primary completion
2023-12-31
Lead sponsor
Zhejiang Provincial People's Hospital
Conditions
Type 2 Diabetes Mellitus; Arteriosclerotic Cardiovascular Disease; Liraglutide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • New-onset cardiovascular events [maximum 2 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.